TGF-β Signaling in the Pathophysiology of the Ovary: A Double-Edged Regulator
Authors:
- Nicole BertaniNBNicole Bertani
- Alessandra AlteriAAAlessandra Alteri
- Luciana CacciottolaLCLuciana Cacciottola
- Giorgia D’addatoGDGiorgia D’addato
- Gina La SalaGSGina La Sala
- Biliana Lozanoska-OchserBLBiliana Lozanoska-Ochser
- Micol MassimianiMicol Massimiani
- Edoardo ParrellaEPEdoardo Parrella
- Alessio ReggioARAlessio Reggio
- Eleonora RussoEleonora Russo
- Federica CampoloFederica Campolo
- Francesca Gioia KlingerFKFrancesca Gioia Klinger
Top Cited Papers
Open Access
- 12 January 2026
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 16 (1) , 130
Abstract
The Transforming Growth Factor-β (TGF-β) superfamily comprises highly conserved cytokines that orchestrate key cellular functions, including proliferation, differentiation, and apoptosis. Within the ovary, TGF-β family members serve as pivotal regulators of folliculogenesis, exerting stage-specific actions from embryonic germ cell development to advanced follicular maturation. During fetal development, activins and SMAD-dependent signaling pathways are essential for primordial germ cell proliferation, survival, and the breakdown of germ cell cysts, enabling the establishment of the primordial follicle pool. Throughout folliculogenesis, TGF-β supports follicle activation, promotes the transition from dormant to growing follicles, stimulates granulosa cell proliferation, sustains follicular viability, and modulates steroidogenesis through theca cell regulation. Notably, anti-müllerian hormone, a TGF-β family member, plays a central role in inhibiting premature follicle recruitment and serves as a key biomarker of ovarian reserve. Dysregulation of TGF-β signaling contributes to various ovarian disorders, including polycystic ovary syndrome and premature ovarian insufficiency. A deeper understanding of these complex signaling networks is critical for identifying novel therapeutic targets and advancing clinical interventions in female reproductive pathologies. This review provides an integrated overview of the roles of the TGF-β superfamily in ovarian physiology and its contributions to disease development.Keywords
This publication has 137 references indexed in Scilit:
- A novel method for purification of biologically active C‐terminal fragment of human recombinant anti‐mullerian hormoneBiomedical Chromatography, 2021
- Fundamental role of BMP15 in human ovarian folliculogenesis revealed by null and missense mutations associated with primary ovarian insufficiencyHuman Mutation, 2020
- Effects of activin A on the transcriptome of mouse oogenesis in vitroJournal of Cellular Physiology, 2019
- Activation of TGF‐β1/Smad3 signaling pathway inhibits the development of ovarian follicle in polycystic ovary syndrome by promoting apoptosis of granulosa cellsJournal of Cellular Physiology, 2018
- The TGFbeta Superfamily Signaling PathwayWIREs Developmental Biology, 2012
- The PI3K/Akt pathway mediates the expression of type I collagen induced by TGF-β2 in human retinal pigment epithelial cellsGraefe's Archive for Clinical and Experimental Ophthalmology, 2011
- Extracellular Regulation of BMP Signaling in Vertebrates: A Cocktail of ModulatorsDevelopmental Biology, 2002
- Characterization of Oocyte and Follicle Development in Growth Differentiation Factor-9-Deficient MiceDevelopmental Biology, 1998
- TGF‐β Latency: Biological Significance and Mechanisms of ActivationStem Cells, 1997
- Transforming growth factor β1 (TGF‐β1) inhibits growth of a human ovarian carcinoma cell line (OVCCR1) and is expressed in human ovarian tumorsInternational Journal of Cancer, 1992